CMPO 144/A: RSU Vesting Leads to 100k-Share Sale via Edward Jones

Rhea-AI Filing Summary

Form 144/A notice documents a proposed sale of 100,000 common shares through Edward Jones with an aggregate market value of $1,796,000.00 and an indicated trading venue of Nasdaq. The filing lists 102,317,852 shares outstanding and an approximate sale date of 08/12/2025. The securities to be sold were acquired as restricted stock units: 62,500 vested on 01/01/2023 and 37,500 vested on 01/01/2024, both shown as vesting from Composecure Inc. The form reports "Nothing to Report" for sales in the past three months and includes the standard signature representation about absence of undisclosed material adverse information. Several administrative fields (filer and issuer name/details and signature/date) are not populated in the visible content.

Positive

• 100,000 common shares clearly identified for proposed sale with aggregate market value $1,796,000.00
• Securities were acquired via RSU vesting on 01/01/2023 and 01/01/2024, shown as vesting events
• Filing reports "Nothing to Report" for securities sold in the past three months

Negative

• The visible filing content does not populate filer identity or complete issuer name/address fields
• No signature or explicit date of notice values are shown in the provided text, limiting verification
• Form text contains minor inconsistencies in naming (e.g., Composecure Inc appears as the RSU source while issuer fields are blank)

Insights

Securities Analyst

TL;DR: Routine Rule 144/A notice for vested RSUs; specified sale appears procedural and not materially disruptive.

The filing shows a proposed sale of 100,000 common shares through Edward Jones with an aggregate market value of $1.796M and identifies the shares as resulting from RSU vesting on 01/01/2023 and 01/01/2024. The form records no sales in the prior three months. As presented, this is a standard disclosure of intent to sell restricted stock under Rule 144 rather than a corporate financing or strategic transaction; the document provides limited operational or financial detail about the issuer itself.

Corporate Governance Expert

TL;DR: Administrative filing includes required representations but some issuer/filer fields are not populated in the visible content.

The notice contains the required statement that the person signing does not possess undisclosed material adverse information and references Rule 10b5-1 trading-plan language if applicable. However, key administrative fields (filer identity, issuer name/address and signature/date entries) are not shown in the provided text, limiting transparency about the selling party and the formal execution of the notice. The lack of populated filer/issuer fields reduces the filing's standalone clarity for investors.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144/A

144/A: Filer Information

Filer CIK
Filer CCC
Previous Accession Number Of The Filing
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144/A: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144/A: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Edward Jones 201 Progress Parkway Maryland Heights MO 63043	100000	1796000.00	102317852	08/12/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144/A: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/01/2023	RSU's	Composecure Inc			62500	01/01/2023	Vesting of RSU's
Common	01/01/2024	RSU's	Composecure Inc			37500	01/01/2024	Vesting of RSU's

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144/A: Securities Sold During The Past 3 Months

Nothing to Report

144/A: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What sale does the CMPO 144/A notice disclose?

The filing discloses a proposed sale of 100,000 common shares with an aggregate market value of $1,796,000.00 via Edward Jones on Nasdaq.

When is the approximate sale date listed in the filing for CMPO?

The filing lists an approximate date of sale of 08/12/2025.

How were the shares to be sold acquired according to the form?

The shares were acquired as RSUs: 62,500 vested on 01/01/2023 and 37,500 vested on 01/01/2024, shown as vesting from Composecure Inc.

Which broker is named for the proposed sale in the CMPO filing?

The filing names Edward Jones (201 Progress Parkway, Maryland Heights MO 63043) as the broker.

Does the filing show recent sales by the reporting person?

No. The form reports "Nothing to Report" under securities sold during the past three months.

Who is identified as the issuer in the filing?

The visible form content does not populate the issuer name field; metadata for this analysis lists the filing title as CompoSecure, Inc. (CMPO), but the issuer entry is not shown in the form text provided.